MY Cancer Services

MY Cancer Services

Find out all you need to know about the cancer services provided by the Trust.

About us

Our vision is to deliver the highest quality of cancer care to the people of Wakefield district and North Kirklees. Find out about the services we offer at Mid Yorkshire for cancer patients and their families.

Oncology 24-hour helpline

You can contact the Oncology 24-hour helpline via the following method.

Monday to Sunday (seven days a week), 24-hours

  • Tel: 01422 222 999

Please note that as of 31 January 2024, the way we provide our Oncology 24-hour helpline changed. The Acute Oncology helpline will now be answered by experienced Oncology Nurses at Calderdale and Huddersfield NHS Foundation Trust (CHFT) 24 hours a day. Please call the above helpline number if you are concerned about side-effects of treatment you are experiencing or are concerned about any symptoms from your cancer.

Find out more about the changes to the Oncology 24-hour helpline.

Cancer Board

The role of the Cancer Board is to provide assurance that there are systems and processes in place to delivery and monitor the Trust’s cancer agenda. The Board ensures that the Quality Committee receive regular reliable assurance on the cancer agenda and associated risks including performance, quality of clinical services, safety, effectiveness and patient experience and advises on the cancer agenda and highlights any risks to delivery.

The Cancer Board consists of  senior managers and clinicians from all specialties and cancer sites. The group will strive to ensure safe and effective  care is delivered within the financial and practical constraints experienced throughout the NHS.

Through delivery of seamless holistic care, across all cancer pathways from suspicion, through diagnosis, to living with and beyond cancer or end-of-life care, the focus of all  our teams will be on improving experience and outcomes.


The Mid Yorkshire Teaching NHS Trust cancer teams work in partnership with many organisations and groups of professionals. Our most important partnership is with our patient and carer groups who help focus our developments in services and identify areas for improvements.

Other partnerships are listed below.

Cancer Locality Group

The aim of the Cancer Locality Group is to ensure the population of Wakefield district and North Kirklees receive cancer services that are high quality, sustainable and responsive to patient needs, represent best value for money and improve patient outcomes and experience.

Membership of the Cancer Locality Group is made up of key representatives involved in cancer services across Wakefield and Kirklees to provide principal clinical and management expertise.

Core membership

  • Senior Commissioning Manager (NHS Wakefield CCG)
  • Transformation Programme Manager (NHS North Kirklees CCG)
  • Cancer Clinical Lead, NHS Wakefield CCG
  • Cancer Clinical Lead, NHS North Kirklees CCG
  • Cancer Clinical Lead, Mid Yorkshire Hospitals NHS Trust
  • Lead Cancer Manager, Mid Yorkshire Hospitals NHS Trust
  • Lead Cancer Nurse, Mid Yorkshire Hospitals NHS Trust
  • Public Health Representative (Local Authority – Wakefield Council and Kirklees Council)
  • Cancer Research UK Representative
  • Patient Representative

This list is not exhaustive and the membership will largely be to the Cancer Locality Group to determine. The Cancer Locality Group meets monthly and the meeting is chaired by the MYHT Lead Cancer Manager.

The Dr Jackson Cancer Fund

The Dr Jackson Cancer Fund, first set up in 1977, has raised more than £1.5 million to help provide cancer care for patients who in the main have been treated within the services offered by the Mid Yorkshire Teaching NHS Trust.

The Charity was launched by a local GP, Dr Ken Jackson, and Urology surgeon Mr Mel Robinson, in order to manage donations handed to them to help and support other cancer patients.

Some of the objectives of the Dr Jackson Cancer Fund is to provide funds for the purchase of equipment for the treatment or prevention of cancer patients and provide funds for Mid Yorkshire to purchase medical and surgical equipment. Fundraising efforts by the Dr Jackson Cancer Fund have helped fund a significant number of equipment, grants, meeting rooms and units for the Mid Yorkshire Teaching NHS Trust.

The Charity always needs volunteers for organising events, tin collections, selling raffle tickets, running a tombola stall plus supporting their retail premises. For more information  visit the Dr Jacksons Cancer Fund website.

Macmillan Cancer Support

Macmillan are a national cancer charity. They provide physical, financial and emotional support from diagnosis, through treatment and beyond for many cancer patients.

They support Mid Yorkshire Teaching NHS Trust with access to funding to support frontline staff, invest in new roles, provide education and support. They provide free information booklets to our patients and host a very informative website. They provide a helpline 7 days a week from 8am-8pm on 0808 808 0000.

To find out how else they work in partnership and what support they provide visit the Macmillan website.

West Yorkshire and Harrogate Cancer Alliance

There are a total of 19 cancer Alliances across the United Kingdom. Alliances bring together NHS organisations, local councils, charities, community and voluntary organisations and groups of patients and families affected by cancer to design and deliver services, reduce variations and share best practice.
For more information visit the Cancer Alliance website.

Documents and reports

The Macmillan Centre Annual Report provides a valuable breakdown of data and information collected from service users, and reveals the impacts that the service is making on those affected by cancer across the Wakefield and North Kirklees district.

Macmillan Centre Quarter 3 Report July-September 2023 [pdf] 2MB

Macmillan Centre Quarter 2 Report April-June 2023 [pdf] 1MB

Macmillan Centre Quarter 1 Report January-March 2023 [pdf] 2MB

Macmillan Centre Annual Report 2022 [pdf] 1MB

Macmillan Centre Annual Report 2021 [pdf] 1MB